Authors:
ORTLEPP D
LAGGERBAUER B
MULLNER S
ACHSEL T
KIRSCHBAUM B
LUHRMANN R
Citation: D. Ortlepp et al., THE MAMMALIAN HOMOLOG OF PRP16P IS OVEREXPRESSED IN A CELL-LINE TOLERANT TO LEFLUNOMIDE, A NEW IMMUNOREGULATORY DRUG EFFECTIVE AGAINST RHEUMATOID-ARTHRITIS, RNA, 4(8), 1998, pp. 1007-1018
Authors:
RUCKEMANN K
FAIRBANKS LD
CARREY EA
HAWRYLOWICZ CM
RICHARDS DF
KIRSCHBAUM B
SIMMONDS HA
Citation: K. Ruckemann et al., LEFLUNOMIDE INHIBITS PYRIMIDINE DE-NOVO SYNTHESIS IN MITOGEN-STIMULATED T-LYMPHOCYTES FROM HEALTHY HUMANS, The Journal of biological chemistry, 273(34), 1998, pp. 21682-21691
Authors:
HERRMANN ML
FRANGOU CG
SIMMONDS HA
KIRSCHBAUM B
Citation: Ml. Herrmann et al., THE PRIMARY-MODE OF ACTION OF LEFLUNOMIDE IN RHEUMATOID-ARTHRITIS IS INHIBITION OF DE-NOVO PYRIMIDINE SYNTHESIS, Arthritis and rheumatism, 41(9), 1998, pp. 17-17
Citation: B. Kirschbaum, HYPERCHOLESTEROLEMIA AS A RISK FACTOR FOR THE PROGRESSION OF CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 342-342
Citation: B. Kirschbaum, THE CONTRIBUTION OF SULFATE TO THE ANION GAP OF CHRONIC-RENAL-FAILURE, Journal of the American Society of Nephrology, 8, 1997, pp. 497-497
Citation: B. Kirschbaum, ACIDOSIS, CORTISOL AND PROTEIN-METABOLISM IN CHRONIC-HEMODIALYSIS PATIENTS, Journal of the American Society of Nephrology, 8, 1997, pp. 1111-1111
Citation: M. Herrmann et al., CELL-CYCLE CONTROL OF THE DE-NOVO PYRIMIDINE SYNTHESIS INHIBITOR LEFLUNOMIDE THROUGH THE P53 AND P21(WAF-1) PATHWAYS, Arthritis and rheumatism, 40(9), 1997, pp. 875-875
Citation: B. Kirschbaum, CORRELATIONS BETWEEN CARNOSINASE ACTIVITY AND NUTRITIONAL PARAMETERS IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1191-1191
Citation: B. Kirschbaum, LIPID-LEVELS AND PLASMA ACTIVITY OF PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(9), 1996, pp. 1192-1192
Citation: B. Kirschbaum et A. Compton, LOSS OF BIOCOMPATIBILITY OF POLYSULFONE DIALYZERS REPROCESSED WITH BLEACH (B) AND FORMALDEHYDE (F), Journal of the American Society of Nephrology, 7(9), 1996, pp. 1193-1193
Authors:
KNECHT W
BERGJOHANN U
GONSKI S
KIRSCHBAUM B
LOFFLER M
Citation: W. Knecht et al., FUNCTIONAL EXPRESSION OF A FRAGMENT OF HUMAN DIHYDROOROTATE DEHYDROGENASE BY MEANS OF THE BACULOVIRUS EXPRESSION VECTOR SYSTEM, AND KINETICINVESTIGATION OF THE PURIFIED RECOMBINANT ENZYME, European journal of biochemistry, 240(1), 1996, pp. 292-301
Citation: B. Kirschbaum, BLOOD-LEVELS OF CARNOSINASE (CSE) IN RENAL-FAILURE PATIENTS RECEIVINGCHRONIC-HEMODIALYSIS, Journal of the American Society of Nephrology, 6(3), 1995, pp. 581-581
Citation: B. Kirschbaum et A. Compton, STUDY OF VASCULAR ACCESS BLOOD-FLOW BY ANGIODYNOGRAPHY, American journal of kidney diseases, 25(1), 1995, pp. 22-25
Citation: B. Kirschbaum et A. Compton, CHANGES IN PLASMA PHOSPHATE CONCENTRATION DURING AND AFTER HIGH-FLUX HEMODIALYSIS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 495-495
Citation: B. Kirschbaum et A. Compton, EFFECT OF BODY-MASS ON UREA REBOUND AFTER HIGH-FLUX HEMODIALYSIS, Journal of the American Society of Nephrology, 5(3), 1994, pp. 495-495
Citation: B. Kirschbaum, THE DECLINE IN SERUM-ALBUMIN AFTER CONVERSION TO HIGH-FLUX, HIGH-EFFICIENCY DIALYSIS, Artificial organs, 18(10), 1994, pp. 729-735
Citation: B. Kirschbaum, THE DECLINE IN SERUM-ALBUMIN AFTER CONVERSION TO HIGH-FLUX, HIGH-EFFICIENCY DIALYSIS, Artificial organs, 18(10), 1994, pp. 729-735
Authors:
KELLY R
KIRSCHBAUM B
CATALA F
SCHNEIDER A
ALONSO S
ROY A
ROEDER RG
BUCKINGHAM M
Citation: R. Kelly et al., TRANSCRIPTIONAL REGULATION OF 2 MOUSE MYOSIN ALKALI LIGHT-CHAIN GENESIN-VITRO AND IN-VIVO, Journal of muscle research and cell motility, 15(2), 1994, pp. 183-183